Endotracheal Tube Market Size Is Expected To Reach USD 3.1 Billion by 2028

 Endotracheal Tube Market Growth & Trends

The global endotracheal tube market size is expected to reach USD 3.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Endotracheal tubes are used to supply oxygen or other gases to the lungs. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and an increasing number of surgical procedures, are expected to propel market growth. In addition, technological development pertaining to endotracheal tubes is further expected to contribute to significant market activities during the forecast period. Recently, Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO₂ and Potassium Titanyl Phosphate (KTP) laser surgeries of the laryngeal or tracheal area.

Certain key factors contributing towards market revenue are the growing need for ventilator-associated with pneumonia and increasing geriatric population that are prone to chronic diseases. As per the World Health Organization (WHO) Report 2019, 4,000,000 people die prematurely due to non-treatment of chronic respiratory diseases. A prominent reason for increasing prevalence of respiratory diseases is air pollution. According to the WHO Report 2019, around 2 billion people globally are exposed to indoor toxic air, 1 billion people are exposed to outdoor pollutant air, and around 1 billion people are exposed to tobacco smoke. The above factors are likely to boost the prevalence of respiratory disorders, which in turn shall boost the demand for endotracheal tubes. With opportunities existing, manufacturers are investing in increasing awareness about the technologically advanced endotracheal tube. For instance, and developments in the field of nanobiotechnology and drug design are spaces that may exhibit higher activities for market growth.

The market witnessed a surge after the outbreak of COVID-19 as breathing difficulty is one of the primary symptoms of the infection, which can lead to collapsed lungs. According to American Association for Bronchology and Interventional Pulmonology, performing tracheostomy was recommended in Covid-19 patients with prolonged mechanical ventilation as it is can reduce the risk of infection, further contributing to market growth. However, a sudden upsurge led to certain mismanagement and chaos initially. By the end of 2020, the industry players had geared themselves up to meet all necessary demands, as well as offer smooth product distribution.

Request a free sample copy or view report summary: Endotracheal Tube Market Report

Endotracheal Tube Market Report Highlights

• By product type, the regular endotracheal tube segment held the largest revenue share of 32.0% in 2020 owing to the increasing prevalence of respiratory diseases
• The orotracheal segment held the largest revenue share and accounted for 64.9% in 2020 owing to its high applicability, increased usage, and ease of use
• Based on the end-use segment, the clinics segment accounted for the largest revenue share in 2020 owing to the shorter waiting time at clinics, convenient access to care, and affordability
• North America accounted for the highest revenue share of 37.9% in 2020 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the region
• Asia Pacific is expected to witness the fastest CAGR of 7.7% over the forecast period. Development in healthcare infrastructure is resulting in an increased number of surgeries being performed, eventually fueling market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-endotracheal-tubes-market

Endotracheal Tube Market Segmentation

Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end-use, and region:

Endotracheal Tube Product Type Outlook (Revenue, USD Million, 2018 - 2028)

• Regular
• Reinforced
• Preformed
• Double lumen

Endotracheal Tube Route Type Outlook (Revenue, USD Million, 2018 - 2028)

• Orotracheal
• Nasotracheal

Endotracheal Tube Application Outlook (Revenue, USD Million, 2018 - 2028)

• Emergency Treatment
• Therapy
• Others

Endotracheal Tube End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Endotracheal Tube Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • New Zealand
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Endotracheal Tube Market

• Teleflex Corporation
• Medtronic
• Medline Industries
• Venner Medical
• Sonoma Pharmaceutical
• Hospiteknik Healthcare
• Armstrong Medical
• Airway Innovations
• Smiths Group
• ConvaTec, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market for Ophthalmic Perimeters to Reflect Steadfast Expansion During 2021-2028: Grand View Research Inc.

 Ophthalmic Perimeters Market Growth & Trends

The global ophthalmic perimeters market size is anticipated to reach USD 371.7 million by 2028, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.3% over the forecast period. The growing frequency of new product launches and an increasing number of strategic alliances between players & end-users are some of the major factors expected to boost growth.

North America is anticipated to dominate the ophthalmic perimeters market during the forecast period owing to rising lifestyle and age-associated ophthalmic conditions such as glaucoma and cataract. An increase in demand for advanced early diagnostic techniques, a high adoption rate for advanced technologies, and favorable reimbursement scenarios are some of the major factors driving the market in the region.

A significant number of ophthalmic perimeter manufacturers are in North America. These players are emphasizing on developing user-friendly ophthalmic perimeter devices by developing image processing software. Moreover, key players are conducting workshops and training programs. Such initiatives are expected to boost the overall growth. The market is witnessing a rise in technologically advanced ophthalmic perimeter devices in the market due to high competition. The development of patented, tablet-based visual field testing and analysis system is anticipated to enable easy, faster, & accurate diagnosis.

Request a free sample copy or view report summary: Ophthalmic Perimeters Market Report

Ophthalmic Perimeters Market Report Highlights

• Static perimeters segment held maximum share in 2018 owing to its extensive use in capturing large data points for visual field testing. Moreover, these devices conduct visual field testing from multiple angles, which in turn helps with an accurate diagnosis.
• Combination perimeters segment is expected to grow at the fastest pace during the forecast period. These devices enable the standardization of procedures and decrease the overall turnaround time.
• Hospital held the largest share among the end-use segment. The high demand for advanced ophthalmic perimeters in hospitals is driving the segment growth.
• Ophthalmic clinic is expected to experience the fastest growth during the forecast period. The segment growth is fueled by an increasing number of standalone ophthalmic clinics in developing regions.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ophthalmic-perimeters-market

Ophthalmic Perimeters Market Segmentation

Grand View Research has segmented the global ophthalmic perimeters market on the basis of product, application, end-use, and region:

Ophthalmic Perimeters Product Outlook (Revenue, USD Million, 2016 - 2028)

• Static
• Kinetic
• Combination

Ophthalmic Perimeters End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Ophthalmic Clinic
• Others

Ophthalmic Perimeters Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Ophthalmic Perimeters Market

• Haag-Streit AG
• Carl Zeiss AG
• Topcon Corporation
• Nidek Co., Ltd.
• Heidelberg Engineering GmbH
• Optopol Technology Sp. z o.o.
• Takagi Seiko Co., Ltd.
• Kowa Company, Ltd.
• Metrovision
• Konan Medical USA, Inc.
• Centervue S.P.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point-of-Care Glucose Testing Market Trends Analysis And Forecast Till 2028: Grand View Research Inc.

 Point-of-Care Glucose Testing Market Growth & Trends

The global point-of-care glucose testing market size is expected to reach USD 4.1 billion by 2028 growing at a CAGR of 3.9%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. 

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Request a free sample copy or view report summary: Point-of-Care Glucose Testing Market Report

Point-of-Care Glucose Testing Market Report Highlights

• Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period
• Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025
• In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry
• North America is the leading regional market due to the higher penetration of novel diagnostic techniques
• Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes
• A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-point-of-care-glucose-testing-market

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market on the basis of product and region:

Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Accu-Chek Inform II
• StatStrip
• Onetouch Verio Flex
• Freestyle Lite
• Accu Check Aviva Meter
• True Metrix
• Bayer CONTOUR Blood Glucose Monitoring System
• i-STAT

Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Point-of-Care Glucose Testing Market

• Hoffmann-La Roche Ltd.
• Abbott
• Nipro
• PlatInium Equity Advisors, LLC (Lifescan, Inc.)
• Nova Biomedical
• ACON Laboratories
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemiluminescence Immunoassay Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Chemiluminescence Immunoassay Market Growth & Trends

The global chemiluminescence immunoassay market size is expected to reach USD 13.75 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Request a free sample copy or view report summary: Chemiluminescence Immunoassay Market Report

Chemiluminescence Immunoassay Market Report Highlights

• Based on product, consumables dominated the market in 2020 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• In terms of application, the infectious disease segment held the largest share in 2020 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
• By end use, in 2020, the hospitals segment accounted for the largest share in 2020 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
• In North America, the U.S. held the largest share in 2020 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
• Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemiluminescence-immunoassay-market

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Chemiluminescence Immunoassay Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
  • Automated
  • Semi-automated
• Consumables
• Software & Services

Chemiluminescence Immunoassay Application Outlook (Revenue, USD Million, 2016 - 2028)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

Chemiluminescence Immunoassay End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Chemiluminescence Immunoassay Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Chemiluminescence Immunoassay Market

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Building-integrated Photovoltaics - Favorable Government Policies for Renewable Energy Installations

 

Know More- https://www.grandviewresearch.com/industry-analysis/building-integrated-photovoltaics-bipv-market

The increasing efforts by the national governments for the installation of solar energy panels are anticipated to drive the market over the next seven years. The rising awareness regarding green infrastructure, including buildings with energy efficiency, is expected to boost the demand for building-integrated photovoltaics (BIPV). BIPV provides a sustainable and effective solution for enhancing the energy efficiency of the structure, retrofitting the exterior of the structure, and providing significant savings in conventional power consumption.

Optical Character Recognition - Increasing Investments In OCR Startup Companies

 

Know More- https://www.grandviewresearch.com/industry-analysis/optical-character-recognition-market

The optical character recognition technology is used to convert content on physical documents into digital form. It helps users to convert different types of images and documents into an editable format. Furthermore, it is used in various industries, such as the logistics and transportation industry, BFSI, and others. Government, banking, retail, healthcare, manufacturing, and other sectors also have wide adoption for OCR technology. With the rising age of digitalization, enterprises invest a lot of money in technologies to increase work efficiency and productivity. 

COVID-19 Vaccine Development Tools Market to Reflect a Holistic Expansion During 2021 to 2028: Grand View Research Inc.

 COVID-19 Vaccine Development Tools Market Growth & Trends

The global COVID-19 vaccine development tools market size is expected to reach USD 30.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. Research professionals across the globe, are rapidly persuading the identification and development of viable candidates to develop COVID-19 immunization shots. This is attributed to the persisting devastation of SARS-CoV-2 across the globe. Additionally, second waves of SARS-CoV-2 infection were expected to coincide with the beginning of winter in the northern hemisphere, indicating the crucial period in the pandemic’s timeline.

Thus, the development of a viable immunization shot is imperative to mitigate the global impact of COVID-19. Acknowledging this need, entities engaged in the development of effective inoculation against COVID-19, are aiming at 4 potential key vaccine candidates, namely, mRNA, recombinant, inactivated, and replication-deficient viral vector. These 4 candidates are the key areas of focus, and the integration of mass spectrometry and chromatography for candidate characterization is common across the development process of all the above candidates.

The spike protein (S-protein) is the most preferred target site with respect to the COVID-19 vaccine target discovery. This is attributed to the fact that the S-proteins are spread throughout the surface of the COVID-19 molecule, which enables attachment to host cell receptors, in turn ensuring easy entry of the virus into the host cell. Active government initiatives aimed at enabling the fast-track development of COVID-19 boosters are expected to create a favorable environment for entities operating in the industry.

For instance, in April 2020, the Access to COVID-19 Tools (ACT) Accelerator was launched aimed at speeding up the delivery and development of COVID-19 boosters. This initiative is inclusive of a health systems connector that supports the delivery of required resources to countries. The tools are also pooled under the umbrella mechanism, namely, the COVAX Facility to ensure effective procurement as well as equitable access to, COVID-19 vaccination and development tools. The ACT Accelerator targets to deliver around 2 billion doses by the end of 2021, across the globe.

Request a free sample copy or view report summary: COVID-19 Vaccine Development Tools Market Report

COVID-19 Vaccine Development Tools Market Report Highlights

• Laboratory technologies have generated the highest revenue in 2020 and this segment is anticipated to maintain its dominance throughout the forecast period
• Significant growth in the adoption of pre-existing laboratory technologies such as PCR, 3D and 2D cell culture products, and flow cytometry is attributive to the segment’s dominance
• The PCR and qPCR segment dominated the market in terms of revenue share in 2020
• The WHO recommends the implementation of rRT-PCR in surveillance of participants for effective COVID-19 vaccine evaluation, which has supplemented a significant surge in the uptake of PCR products
• Detecting new mutations in SARS-CoV-2 enables research professionals to reconstruct unknown infection routes along with establishing a molecular basis for COVID-19 vaccine design
• This has widely promoted the usage of NGS particularly across molecular typing and genomic epidemiology applications, making it the fastest-growing segment throughout the forecast period
• Interactive web tools have emerged as dominant online technologies employed in COVID-19 vaccine development and research
• Online interactive web tools have gained sufficient traction amongst the researchers and vaccine developers as these entail interactive graphs, maps, and dashboards that assist in effective monitoring of vaccine development while avoiding any misinformation
• Vaccine research has witnessed the highest penetration of COVID-19 vaccine development tools, leading to the segment’s largest share in 2020
• Large-scale adoption of tools associated with nucleic acid isolation and purification, real-time PCR, Sanger sequencing, mass spectrometry, and NGS among others has contributed to the segment’s dominance
• The contract research organization (CROs) end-use segment is expected to grow at a fast pace through 2021 - 2028. Partnerships with CROs are proving integral as they ensure access to a vast number of resources along with expanded expertise
• North America dominated the market and accounted for the largest revenue share in 2020; U.S. ranked 1^stin this region, in terms of revenue
• More than 20% of the vaccines being developed across the globe hail from the U.S., thus, providing immense lucrative opportunities for the market players operational in the country

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-vaccine-development-tools-market

COVID-19 Vaccine Development Tools Market Segmentation

Grand View Research has segmented the global COVID-19 vaccine development tools market on the basis of technology, application, end use, and region:

COVID-19 Vaccine Development Tools Technology Outlook (Revenue, USD Million, 2020 - 2028)

• Laboratory Technologies
  • Next Generation Sequencing
  • PCR & qPCR
  • Flow Cytometry
  • Spectrometry
  • Microscopy&Electron Microscopy
  • Preparative & Process Chromatography
  • Nucleic Acid Isolation & Purification
  • Transfection Electroporation
  • Cell Culture
  • Automated Liquid Handling
• Online Technologies
  • Interactive Web Technologies
  • Vaccine Management & Tracker Technologies

COVID-19 Vaccine Development Tools Application Outlook (Revenue, USD Million, 2020 - 2028)

• Vaccine Research
• Vaccine Process Development
• Vaccine Quality Assurance/Quality Control

COVID-19 Vaccine Development Tools End-use Outlook (Revenue, USD Million, 2020 - 2028)

• Pharma & Biopharma Companies
• Contract Research Organization (CROs)
• Academic & Research Institutes

COVID-19 Vaccine Development Tools Regional Outlook (Revenue, USD Million, 2020 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of COVID-19 Vaccine Development Tools Market

• Thermo Fisher Scientific, Inc.
• Celerion
• Cole-Parmer Instrument Company, LLC.
• Pfizer Inc.
• Sartorius AG
• STEMCELL Technologies Inc.
• AB SciexPte. Ltd.
• Illumina, Inc.
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Danaher
• Merck KGaA
• Qiagen N.V.
• Shimadzu Corporation
• Eurofins Scientific
• Charles River Laboratories
• Takara Bio Inc.
• PerkinElmer Inc.
• Fluidigm
• OLYMPUS CORPORATION
• Avantor, Inc.
• Polyplus Transfection
• Hamilton Company
• Aurora Biomed Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Intravenous Immunoglobulin Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 U.S. Intravenous Immunoglobulin Market Growth & Trends

The U.S. intravenous immunoglobulin market size is expected to reach USD 10.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2021 to 2028. Robust pipeline, approval and launch of novel products, and increasing government initiatives are expected to be the major factors driving the market.

Robust pipeline and increasing approvals and launches of novel products are anticipated to support the market growth over the forecast period. For instance, in April 2019, U.S.-based ADMA Biologics, Inc. received U.S. FDA approval for its new drug Asceniv. It is an IVIG drug indicated for the treatment of primary humoral immunodeficiency disease. Similarly, in December 2019, CSL Behring announced receiving orphan drug exclusivity for Hizentra from the U.S. FDA to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). In another instance, in February 2021, Biotest AG announced that it was the first in Germany to manufacture an investigational hyper immunoglobulin from plasma protein for the COVID-19 treatment.

Furthermore, increasing initiatives by various government organizations to boost the development of novel products are expected to support market growth over the forecast period. For instance, in January 2018, the National Institutes of Health (NIH) awarded a grant of USD 3 million to the U.S.-based GigaGen Inc. to develop novel recombinant intravenous immunoglobulin for patients with primary immunodeficiency diseases.

However, the manufacturing of IVIG requires a well-developed production facility and high capital investments, thereby leading to the high cost of the final product. Hence, this factor is anticipated to restrain the market growth. In addition, IVIG products undergo stringent regulations pertaining to safety and handling, which is another factor expected to impede the market growth. For instance, in 2018, the U.S. FDA delayed the approval of GC Pharma’s intravenous immunoglobulin product and demanded additional data related to the drug’s manufacturing process.

Request a free sample copy or view report summary: U.S. Intravenous Immunoglobulin Market Report

U.S. Intravenous Immunoglobulin Market Report Highlights

• By application, immunodeficiency diseases dominated the market in 2020 owing to the rising number of cases and the growing adoption of IVIG for the treatment of these diseases
• The multifocal motor neuropathy application segment is expected to register the fastest growth rate over the forecast period due to the high effectivity of IVIG in its treatment
• Based on distribution channel, hospital pharmacy held the largest share in 2020 owing to a large number of hospital pharmacies and the easy availability of products in the hospitals
• Market leaders are involved in the development of new plasma collection centers and other collaborative strategies to expand their geographical reach and widen their product portfolio

Access Press Release@ https://www.grandviewresearch.com/press-release/us-intravenous-immunoglobulin-ivig-market-analysis

U.S. Intravenous Immunoglobulin Market Segmentation

Grand View Research has segmented the U.S. intravenous immunoglobulin market on the basis of application and distribution channel:

U.S. IVIG Application Outlook (Revenue, USD Million, 2016 - 2028)

• Hypogammaglobulinemia
• CIDP
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-barre Syndrome
• Others

U.S. IVIG Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Pharmacy
• Specialty Pharmacy
• Others

List of Key Players of U.S. Intravenous Immunoglobulin (IVIG) Market

• Biotest AG
• Octapharma AG
• LFB Biotechnologies S.A.S
• China Biologics Products Holdings, Inc.
• Grifols, S.A.
• Kedrion Biopharma, Inc.
• CSL Behring
• McKesson Corporation
• Takeda Pharmaceutical Company Limited
• Bio Products Laboratory Ltd.
• Pfizer, Inc.
• ADMA Biologics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Snares Market Report by Opportunity, Demand, Recent Trends, Major Driving Factors and Business Growth Strategies

 Surgical Snares Market Growth & Trends

The global surgical snares market size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.4% from 2021 to 2028. The market is primarily driven by various factors such as an increase in the number of endoscopic ambulatory surgery centers and polypectomy procedures and the growing preference for minimally invasive surgeries. A significant increase in the number of gastrointestinal procedures in the U.S. and other developed economies is anticipated to support the market growth over the forecast period. Moreover, the increasing prevalence of chronic kidney diseases, the growing geriatric population suffering from chronic conditions, and increasing patient awareness are among the factors aiding in the market growth. Favorable reimbursement policies in major markets are promoting demand for surgical snares in various medical procedures.

A constant rise in the geriatric population is leading to an increase in the financial burden on the healthcare system. According to the Population Reference Bureau, the number of people in the U.S. aged 65 and above is estimated to nearly double from 52 million in 2018 to 95 million by 2060. Such a rise in the elderly population is expected to subsequently result in greater demand for ablation devices for the treatment of tumors, thereby boosting the market growth.

Technological advancements in minimally invasive surgeries are further expected to drive the demand for endoscopy procedures, which, in turn, is anticipated to fuel the growth of the market. For instance, in March 2018, Auris Health, Inc. received FDA approval for its new robotic endoscopy system, Monarch Platform. In another instance, in June 2017, Olympus introduced a 3D surgical endoscope, which is compatible with the VISERA ELITE II system.

Request a free sample copy or view report summary: Surgical Snares Market Report

Surgical Snares Market Report Highlights

• By usability, the single-use segment accounted for the largest revenue share of over 60.0% in 2020 owing to the high adoption of single-use instruments in medical settings
• Based on application, the GI endoscope segment held the largest share in 2020 due to factors such as large procedural volume and the availability of advanced products
• The hospitals end-use segment held the largest share in 2020 due to the high number of patient visits and advanced infrastructure in hospitals as compared to other healthcare facilities
• North America held the largest share in 2020 and is predicted to maintain its lead over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-snares-market

Surgical Snares Market Segmentation

Grand View Research has segmented the global surgical snares market on the basis of usability, application, end use, and region:

Surgical Snares Usability Outlook (Revenue, USD Million, 2016 - 2028)

• Single-use
• Reusable

Surgical Snares Application Outlook (Revenue, USD Million, 2016 - 2028)

• GI Endoscope
• Laparoscopy
• Urology Endoscopy
• Gynecology Endoscopy
• Arthroscopy
• Bronchoscopy
• Mediastinoscopy
• Laryngoscopy
• Others

Surgical Snares End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers

Surgical Snares Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Surgical Snares Market

• Medtronic
• Boston Scientific Corporation
• Medline Industries, Inc.
• Olympus Corporation
• Cook
• CONMED Corporation
• Steris (U.S.)
• Merit Medical Systems
• Avalign Technologies
• Hill-Rom Holdings, Inc.
• Sklar Surgical Instruments

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurovascular Catheters Market Size Is Anticipated To Reach USD 4.83 Billion by 2028

 Neurovascular Catheters Market Growth & Trends

The global neurovascular catheters market size is anticipated to reach USD 4.83 billion by 2028, expanding at a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.

Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country.

Various initiatives are undertaken by the government worldwide to prevention stroke. For instance, the Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program was started by the U.S. CDC in three states: North Carolina, Massachusetts, and Arizona, to minimize the risk of stroke and other neurovascular diseases in women by promoting a healthy lifestyle.

Request a free sample copy or view report summary: Neurovascular Catheters Market Report

Neurovascular Catheters Market Report Highlights

• By type, embolization neurovascular catheters dominated the neurovascular catheters market in 2019 owing to the increasing prevalence of conditions, such as brain aneurysms, nose bleeding, and arteriovenous malformations
• Based on application, the others segment is expected to expand at the highest CAGR during the forecast period owing to the rising number of patients suffering from neurovascular diseases and conditions, such as carotid artery stenosis and atherosclerosis
• Based on end-use, hospitals dominated the market in 2019 owing to factors, such as rising prevalence of acute ischemic stroke, growing awareness among the population, and increasing government funding
• North America dominated the market with the largest share in 2019 owing to rising incidence of hemorrhagic stroke and brain aneurysm and increasing R&D investment
• Some of the key players operating in the neurovascular catheters market are Medtronic; Stryker; phenox GmbH; Penumbra, Inc.; Integer holdings Corporation; Terumo Corporation; Integra LifeSciences Corporation; Biomerics; Acandis GmbH; and Spiegelberg GmbH & Co. KG.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-neurovascular-catheters-market

Neurovascular Catheters Market Segmentation

Grand View Research has segmented the global neurovascular catheters market on the basis of type, application, end-use, and region:

Neurovascular Catheters Type Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Neurovascular Catheters Application Outlook (Revenue, USD Million, 2016 - 2028)

• Embolic Stroke
• Brain Aneurysm
• Arteriovenous Malformations
• Others

Neurovascular Catheters End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Neurovascular Catheters Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Neurovascular Catheters Market

• Medtronic
• Stryker
• phenox GmbH
• Penumbra, Inc.
• Integer Holdings Corporation
• Terumo Corporation
• Integra LifeSciences Corporation
• Biomerics
• Acandis GmbH
• Spiegelberg GmbH & Co. KG.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cardiovascular Ultrasound Market Size Is Expected To Reach USD 2.33 Billion by 2028

 Cardiovascular Ultrasound Market Growth & Trends

The global cardiovascular ultrasound market size is expected to reach USD 2.33 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.7% over the forecast period. Rising investment in the Medtech industry, increasing R&D activities, and high prevalence of cardiovascular diseases are the key factors driving market growth.

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2017. Favorable reimbursement framework and presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

Some of the key players in the cardiovascular ultrasound market include Philips; GE Healthcare, Inc.; Hitachi; Fujifilm Medical Systems; Siemens Healthcare; and Canon Medical Systems Corporation.

Request a free sample copy or view report summary: Cardiovascular Ultrasound Market Report

Cardiovascular Ultrasound Market Report Highlights

• Cardiovascular ultrasound market was valued at USD 1.38 billion in 2017 and is expected to grow lucratively over the forecast period
• Fetal echocardiography segment is anticipated to expand at the fastest CAGR
• Doppler segment was valued at USD 0.6 billion in 2017 and is anticipated to rise at a lucrative CAGR during the forecast period
• Ambulatory care centers segment is expected to witness the fastest CAGR in the forthcoming years.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cardiovascular-ultrasound-cvus-market

Cardiovascular Ultrasound Market Segmentation

Grand View Research has segmented the global cardiovascular ultrasound market report on the basis of type, technology, display, end-use, and region:

Cardiovascular Ultrasound Type Outlook (Revenue, USD Million, 2016 - 2028)

• Transthoracic Echocardiography
• Transesophageal Echocardiography
• Fetal Echocardiography
• Others

Cardiovascular Ultrasound Technology Outlook (Revenue, USD Million, 2016 - 2028)

• 2D
• 3D/4D
• Doppler

Cardiovascular Ultrasound Display Outlook (Revenue, USD Million, 2016 - 2028)

• B/W
• Color

Cardiovascular Ultrasound End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Diagnostic Centers
• Ambulatory Care Centers
• Others

Cardiovascular Ultrasound Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

Key Players of Cardiovascular Ultrasound Market

• GE Healthcare
• Koninklijke Philips
• Siemens Healthineers AG
• Hitachi Medical Corp.
• Samsung Medison Co. Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)
• Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
• Fujifilm Sonosite, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

5G Services- Potential Waiting To be Tapped

 

Know More- https://www.grandviewresearch.com/industry-analysis/5g-services-market

5G wireless mobile services enable a fully mobile and connected environment by delivering a wide range of use cases and business models to consumers. Moreover, faster data speeds and extremely low latency offered by the 5G technology would enhance the user experience while using 5G services for several use cases, such as Virtual Reality (VR) and Augmented Reality (AR) gaming, seamless video calling, and Ultra-High Definition (UHD) videos, among others. The growing demand for high-speed data connectivity for unified Internet of Things (IoT) applications, such as smart home energy management, is estimated to propel the adoption of these services over the forecast period.

The Rise of Real Time Payments

 

Know More- https://www.grandviewresearch.com/industry-analysis/real-time-payments-market

Real-time payments can also help businesses in strengthening their cash flows and subsequently in improving their operational efficiencies, budgeting, and overall cash management. Hence, the growing preference for this payment mode among businesses is particularly expected to drive the market growth. A survey conducted by ACI Worldwide, a payment system company, in 2018 revealed that 77% of the merchants worldwide are expecting real-time payments to replace physical payment cards.